The company is preparing to submit the results to the FDA this year
Category: News
The agency has launched a whole genome sequencing service to monitor the virus
VIDAR-1 trial marks company’s clinical-stage debut
Collaboration brings remote care to cancer patients
EC extends brexpiprazole indication to include adolescents
Immunoglobulin therapy improves mobility in phase 2/3 study
Phase 2a TREE study assesses safety and efficacy of leriglitazone
Company seeks new direction after negative CHMP opinion on KIZFIZO
CervoMed’s therapy demonstrates significant improvement in patients
Oxford Medical Products targets overweight individuals